Preliminary studies indicate that the compound – a dual stimulator of GLP-1 and glucose-dependent insulinotropic polypeptide receptors – offers a considerable breakthrough in weight reduction programs . Unlike existing treatments , this dual-action compound seems to influence food intake and ener